Listed

Nephros Inc

NEPHNasdaqCIK 1196298HealthcareFiscal year ends Dec 31

Reports and events: 317 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Nephros Inc, Reports and events
FiledFormWhat it isAccession number
2022-11-2116:01 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001493152-22-033098
2022-11-1516:27 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-032511
2022-11-0216:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-030207
2022-10-1107:30 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-028035
2022-09-0817:24 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-025393
2022-08-2316:30 ET8-K5.02 Departure or appointment of officers or directors0001493152-22-023841
2022-08-1516:45 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-022929
2022-08-1016:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-021892
2022-07-0608:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-018632
2022-05-2016:00 ET8-K5.07 Shareholder vote results0001493152-22-014596
2022-05-1716:46 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-014190
2022-05-0510:53 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-012190
2022-05-0416:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-012079
2022-04-1316:37 ETDEF 14AProxy statementPeriod 2022-04-130001493152-22-009823
2022-03-0316:30 ET10-KAnnual reportPeriod 2021-12-310001493152-22-005976
2022-02-2316:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-005242
2022-01-1307:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-001104
2021-12-0316:38 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-21-030449
2021-11-0416:17 ET10-QQuarterly reportPeriod 2021-09-300001493152-21-027249
2021-10-0807:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-025001
2021-09-0208:53 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-021834
2021-08-0516:27 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-018731
2021-08-0516:16 ET10-QQuarterly reportPeriod 2021-06-300001493152-21-018725
2021-07-1210:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-21-016611
2021-07-0809:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-016427
2021-06-1112:51 ETSC 13D/AOwnership report, active investor, amended0001493152-21-014112
2021-05-2017:20 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001493152-21-012384
2021-05-0616:16 ET10-QQuarterly reportPeriod 2021-03-310001493152-21-010619
2021-05-0616:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-010622
2021-04-0716:15 ETDEF 14AProxy statementPeriod 2021-04-070001493152-21-008202
2021-04-0507:47 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-007931
2021-03-3116:15 ET8-K5.02 Departure or appointment of officers or directors0001493152-21-007458
2021-03-2917:15 ET8-K8.01 Other events0001493152-21-007082
2021-03-0116:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-005096
2021-03-0116:16 ET10-KAnnual reportPeriod 2020-12-310001493152-21-005090
2021-02-0317:10 ET8-K5.02 Departure or appointment of officers or directors0001493152-21-002532
2021-01-1210:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-21-000826
2020-11-0516:18 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-020597
2020-11-0516:06 ET10-QQuarterly reportPeriod 2020-09-300001493152-20-020593
2020-10-2916:15 ET8-K5.02 Departure or appointment of officers or directors0001493152-20-020123
2020-10-2616:42 ETSC 13D/AOwnership report, active investor, amended0001048462-20-000019
2020-10-2113:15 ETSC 13D/AOwnership report, active investor, amended0001140361-20-023502
2020-10-2016:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-20-019667
2020-10-1607:45 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-019530
2020-10-1316:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-20-019345
2020-10-0608:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-20-018976
2020-08-1416:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-015844
2020-08-0516:20 ET8-K/A5.07 Shareholder vote results0001493152-20-014726
2020-08-0516:20 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-014725
2020-08-0516:05 ET10-QQuarterly reportPeriod 2020-06-300001493152-20-014717

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.